Treatment · UDEI proprietary

UltraView DEL™

UDEI’s proprietary intense pulsed light (IPL) therapy targets the inflammation and meibomian gland dysfunction at the root of most dry eye disease. Over 3–4 sessions, UltraView DEL reduces vascular inflammation, restores gland function, and delivers lasting comfort.

Book Assessment

15 min

Per session

3–4

Sessions (2–4 weeks apart)

80%

Improvement after full course

Downtime

Why IPL is different

An Active Treatment, Not a Passive One

Most dry eye treatments are passive — drops, gels, and plugs manage symptoms but don’t address the underlying biology. UltraView DEL is active. It uses precisely calibrated intense pulsed light (IPL) to target the inflammation and meibomian gland dysfunction that cause the majority of dry eye disease.

Where conventional approaches provide temporary relief, IPL therapy works at the cellular level: collapsing the abnormal blood vessels that drive chronic eyelid inflammation, stimulating meibomian gland secretion, and reducing the bacterial toxins that degrade your tear film. The result is a measurable improvement in tear quality and ocular surface health — not just temporary symptom masking.

Why “UltraView DEL”?

UltraView DEL is UDEI’s proprietary IPL protocol, developed and refined by our dry eye specialists. “DEL” stands for Dry Eye Light — a treatment pathway designed specifically for ocular surface disease, not adapted from dermatological IPL. The protocol, settings, and treatment sequence are calibrated for the unique anatomy and biology of the eyelid and tear film.

Four mechanisms of action

How UltraView DEL Works

UltraView DEL uses precisely calibrated light wavelengths to address dry eye through four complementary biological pathways. Each mechanism reinforces the others, producing a cumulative therapeutic effect across the treatment course.

Reduce Inflammation

IPL collapses abnormal blood vessels (telangiectasia) around the eyelid margin that drive chronic inflammation. By eliminating these vessels, the inflammatory cascade is interrupted at its source — not just suppressed with medication.

Restore Glands

Controlled thermal energy stimulates meibomian gland secretion and helps unblock obstructed glands. The glands resume producing healthy meibum — the lipid layer that prevents your tears from evaporating too quickly.

Decrease Toxins

IPL reduces bacterial lipase production on the eyelid surface. These bacterial enzymes break down the lipid layer of your tear film, accelerating evaporation. Reducing them allows your tear film to remain stable longer.

Promote Healing

Increased blood flow to the treated area supports corneal and conjunctival repair. The combined anti-inflammatory and restorative effects create conditions for the ocular surface to heal and stabilize.

Who benefits

Who UltraView DEL Is For

UltraView DEL is designed for patients whose dry eye is driven by inflammation and meibomian gland dysfunction — the most common underlying causes. Your comprehensive evaluation determines whether IPL is the right path for your specific presentation.

Moderate-to-severe dry eye

Patients with persistent symptoms — grittiness, burning, redness, foreign body sensation — that haven’t responded adequately to drops, warm compresses, or other first-line treatments.

Inflammatory dry eye

Meibomian gland dysfunction

Patients with clinically confirmed MGD: blocked or underperforming glands, lipid deficiency in the tear film, and evaporative symptoms. Imaging confirms the glands are present but obstructed.

Evaporative dry eye

Chronic blepharitis

Patients with ongoing eyelid margin inflammation, crusting, or redness that contributes to tear film instability. IPL addresses the vascular inflammation that perpetuates the blepharitis cycle.

Lid margin disease

Reducing drop dependency

Patients who want to move beyond frequent artificial tear use and address the underlying problem. Many patients reduce their drop frequency significantly after completing the IPL course.

Long-term comfort

Post-inflammatory dry eye

Patients whose dry eye developed after an inflammatory event — surgery, infection, or systemic condition — and whose ocular surface remains unstable despite conventional treatment.

Secondary dry eye

Not ideal: contraindications

Active eye infection, recent eyelid surgery (wait 3+ months), certain photosensitizing medications, pregnancy, or severe actinic eyelid damage. Your evaluation will clarify suitability.

Discuss at evaluation

What to expect

The Treatment Protocol: Step by Step

Each UltraView DEL session takes approximately 15 minutes. Most patients complete 3–4 sessions spaced 2–4 weeks apart. Here’s what a typical session looks like.

Protective eyewear

Specialized protective shields are placed over your eyes to ensure complete safety during the light pulses. Your clinician verifies proper fit before proceeding.

Cooling gel application

A thin layer of cooling gel is applied to the treatment area around your eyelids. This ensures even light distribution and protects the skin surface during treatment.

Calibrated light pulses

The IPL handpiece delivers precisely calibrated light pulses to the upper and lower eyelid areas. Settings are customized for your skin type and eye anatomy. You’ll feel gentle warmth — some patients describe a faint snapping sensation.

Meibomian gland expression

Following the light pulses, your clinician may perform gentle manual expression of the meibomian glands while they are warm and responsive. This helps clear any remaining obstructions.

Done — zero downtime

The gel is removed and you’re finished. Return to normal activities immediately. No restrictions on screens, driving, or exercise. Some patients notice mild redness around the treated area that resolves within hours.

The treatment course

Session 1: Baseline treatment, initial gland stimulation and inflammation reduction. Sessions 2–3: Reinforcement — continued inflammation reduction and gland restoration. Session 4: Final optimization of results. Some patients see benefit after 2 sessions; others benefit from the full course. We assess your response at each visit and recommend the optimal number for your eyes.

The timeline

Results and What Improves

IPL results build progressively across the treatment course. While some patients notice modest improvement after the first session, the full benefit emerges after 2–4 sessions as inflammation reduces and gland function normalizes.

After session 1: some patients notice modest improvement; others see more benefit as sessions continue
After sessions 2–3: 60–70% of patients report significant symptom improvement — reduced grittiness, burning, and redness
After full course (3–4 sessions): 80% of patients see improved tear stability, reduced inflammation markers, and measurable comfort gains
What improves: dryness, redness, foreign body sensation, blurred vision, and drop dependency — many patients reduce or discontinue frequent artificial tears
3–6 months: typical benefit period with proper home care (lid hygiene, omega-3 supplementation, warm compresses)
6–12+ months: many patients maintain results long-term; some benefit from annual “touch-up” sessions to sustain improvement

We track your progress objectively at each follow-up visit: tear osmolarity, lipid layer quality, meibomian gland expression, and ocular surface staining. These measurements confirm that treatment is working — not just how you feel, but what we can measure.

Safety profile

UltraView DEL has an excellent safety profile when performed by trained optometrists. Potential side effects are rare and mild: temporary redness on treated skin (resolves within hours), minimal discomfort during treatment, and very rarely, transient pigmentation changes in lighter skin types. Pre-treatment screening ensures you’re a safe candidate.

Connected care

UltraView DEL Within the UVG Ecosystem

IPL is rarely the only tool. Dry eye is often multifactorial, and our integrated network lets us coordinate care across expertise without scattering you between separate institutions.

Post-cataract dry eye? Our colleagues at Uptown Eye Specialists refer their most challenging post-surgical dry eye cases to UDEI. UltraView DEL addresses the inflammation that often flares after cataract surgery, restoring comfort and tear stability during the critical healing window.

Post-LASIK dry eye? Patients from U Eye Laser Cosmetic whose dry eye persists beyond the typical recovery period benefit from IPL’s targeted anti-inflammatory action — addressing the root cause rather than relying on drops indefinitely.

Combination therapy? Many patients benefit most from UltraView DEL + LipiFlow — IPL reduces inflammation while thermal pulsation mechanically unblocks glands. Treating different mechanisms in a coordinated sequence delivers better outcomes than either approach alone.

Home-care support? Warm compresses, omega-3 supplementation, and lid-hygiene products that complement your IPL treatment are curated by our clinicians and available through U Shoppe.

Common questions

Frequently Asked Questions

No. Most patients describe UltraView DEL as comfortable — a gentle warm pulse, similar to brief sun exposure on the skin. Protective eyewear shields your eyes throughout. Some patients notice a faint snapping sensation during the light pulses, but pain is not expected. If you have concerns about sensitivity, discuss them at your evaluation and your clinician can adjust settings accordingly.

Most patients benefit from 3–4 sessions spaced 2–4 weeks apart. Some patients see meaningful improvement after just 2 sessions, while others benefit from the full course of 4. Your clinician assesses your response at each visit and recommends the optimal number for your specific presentation. There is no fixed protocol — treatment is tailored to your clinical response.

Absolutely. Many patients achieve the best results from combination therapy. UltraView DEL pairs well with LipiFlow (IPL reduces inflammation while thermal pulsation mechanically unblocks glands), BlephEx (mechanical biofilm removal), and punctal plugs (tear conservation). Your clinician will recommend the optimal combination based on your specific dry eye type and severity.

Most patients enjoy 3–6 months of significant benefit after completing the treatment course. With consistent home care — warm compresses, lid hygiene, and omega-3 supplementation — many patients maintain improvement for 12 months or longer. Dry eye is chronic, so some patients benefit from an annual maintenance session. Your clinician will discuss the long-term plan at your follow-up visits.

UltraView DEL is a specialist treatment not covered by most provincial health plans. Private insurance coverage varies — some plans cover a portion of IPL therapy for diagnosed dry eye disease. We recommend checking with your insurer before starting treatment. Our team can provide the documentation your insurer may require, including diagnostic codes and clinical rationale.

Take the next step

Is UltraView DEL Right For You?

A comprehensive dry eye evaluation is the first step. Our specialists will assess your meibomian gland structure and function, measure your tear film stability, and evaluate your inflammation markers to determine whether IPL is the right treatment path for your unique clinical picture.